4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0001193125-25-230084
CEO sold 50,000 shares at an average $24.57 ($1,228,323)
- CEO acquired 50,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…